Records containing: Type 2 Diabetes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2008-06-12Gene Expression Profiling by DNA Chips and Subsequent Bioinformatic Analysis for Identification of Genes and Biochemical Pathways Associated With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2008-06-10The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Subjects During Hypoglycemia Assessed by Positron Emission Tomography
-
CLINICAL_TRIALS study record update · 2008-05-28An Open Label Follow-On Study of Safety and Pharmacodynamic Effects of 24 Weeks of Treatment With DIO-902 in Combination With Metformin and Atorvastatin in Subjects With Type 2 Diabetes Mellitus (Protocol No. DIO-503)
-
CLINICAL_TRIALS study record update · 2008-05-23Vitamin D Supplementation to Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2008-05-22ClinicalTrials.gov study NCT00544518
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-05-22Effects Polyphenol Containing Antioxidants on Oxidative Stress in Diabetic Patients
-
CLINICAL_TRIALS study record update · 2008-05-21Study of Gene Expression in Fat and Muscle Tissue in Type 2 Diabetics and Healthy Controls During Experimental Endotoxemia
-
CLINICAL_TRIALS study record update · 2008-05-20ClinicalTrials.gov study NCT00536549
-
CLINICAL_TRIALS study record update · 2008-03-17A 24-Week Randomised, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Added to the Therapy of Patients With Type 2 Diabetes Poorly Controlled on Sulphonylurea Alone
-
CLINICAL_TRIALS study record update · 2008-03-17A 24-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Administered as Monotherapy to Drug-Naïve Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2008-03-17An Open-Label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar 1 mg in Patients With Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS study record update · 2008-03-17A 52-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy When Administered to Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2008-03-17A Long-Term, Post-Treatment, Safety Follow-Up, Multi-Center Study in Patients With Type 2 Diabetes Mellitus From the GALLANT, GALLEX or ARMOR Studies.
-
CLINICAL_TRIALS study record update · 2008-03-17A Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar Therapy in Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2008-03-17A 16-Week Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo- and Active- (Metformin) Controlled Study to Evaluate the Effect on Whole Body Insulin Sensitivity of Tesaglitazar Therapy When Administered to Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2008-03-11A Study Assessing an Injection Port for Administration of Insulin
-
CLINICAL_TRIALS study record update · 2008-03-03Randomized Strategy Trial Comparing Detection of Silent Ischemia With no Detection of Silent Ischemia in Asymptomatic Patients With Type 2 Diabetes Mellitus. Effects on Cardiovascular Events.
-
CLINICAL_TRIALS study record update · 2008-02-25Comparison of High Monounsaturated Fat and High Carbohydrate Diets on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2008-02-22A Phase 1/2a, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Study of Safety, Tolerability, Pharmacokinetics and Activity of 14 Days of Oral Dosing With the 2S,4R Enantiomer of Ketoconazole (DIO-902) in Subjects With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2008-02-14GOAL Life-Style Change Implementation Intervention to Prevent Type 2 Diabetes in Primary Health Care
-
CLINICAL_TRIALS study record update · 2008-02-12Four Weeks of Near Normalisation of Blood Glucose Improves the Insulin Response to GLP-1 and GIP in Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2008-02-07Differences in Metabolic and Cardiovascular Effects of Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2008-01-09A Multi-Center, 52-Week, Open-Label Extension Study (From Studies WEL-301, WEL-302, and WEL-303) to Evaluate the Long-Term Safety and Tolerability of WelChol® in Type 2 Diabetic Patients
-
CLINICAL_TRIALS study record update · 2007-12-28A Comparison of NMR and Chemical Lipid Analysis in the Fasting and Postprandial State in Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2007-12-19The Effect of Insulin Glargine on Glycemic Control, Morbidity, and Length of Stay in Hospitalized Subjects With Diabetes Receiving Enteral Nutrition